AI Article Synopsis
- The study aimed to investigate the expression levels of somatostatin receptor subtype 2 (SST2R) in pancreatic cancer tissues compared to adjacent non-cancerous tissues, and its link to genes involved in tumor angiogenesis.
- Out of 40 pancreatic cancer patients, a significant majority (87.5%) showed negative SST2R expression in cancer tissues, while 85% of adjacent tissues were positive, indicating a notable difference in SST2R expression levels between the two types of tissue.
- Additionally, SST2R expression correlated negatively with the tumor suppressor genes p53 and ras, suggesting that decreased SST2R levels may contribute to pancreatic carcinogenesis and could influence treatment outcomes with somatostatin analogs.
Article Abstract
Aim: To explore the difference of somatostatin receptor subtype 2 (SST2R) gene expression in pancreatic cancerous tissue and its adjacent tissue, and the relationship between the change of SST2R gene expression and pancreatic tumor angiogenesis related genes.
Methods: The expressions of SST2R, DPC4, p53 and ras genes in cancer tissues of 40 patients with primary pancreatic cancer, and the expression of SST2R gene in its adjacent tissue were determined by immunohistochemiscal LSAB method and EnVision(TM) method. Chi-square test was used to analyze the difference in expression of SST2R in pancreatic cancer tissue and its adjacent tissue, and the correlation of SST2R gene expression with the expression of p53, ras and DPC4 genes.
Results: Of the tissue specimens from 40 patients with primary pancreatic cancer, 35 (87.5%) cancer tissues showed a negative expression of SST2R gene, whereas 34 (85%) a positive expression of SST2R gene in its adjacent tissues. Five (12.5%) cancer tissues and its adjacent tissues simultaneously expressed SST2R. The expression of SST2R gene was markedly higher in pancreatic tissues adjacent to cancer than in pancreatic cancer tissues (P<0.05). The expression rates of p53, ras and DPC4 genes were 50%, 60% and 72.5%, respectively. There was a significant negative correlation of SST2R with p53 and ras genes (chi(1)(2)=9.33, chi(2)(2)=15.43, P<0.01), but no significant correlation with DPC4 gene (chi(2)=2.08, P>0.05).
Conclusion: There was a significant difference of SST2R gene expression in pancreatic cancer tissues and its adjacent tissues, which might be one cause for the different therapeutic effects of somatostatin and its analogs on pancreatic cancer patients. There were abnormal expressions of SST2R, DPC4, p53 and ras genes in pancreatic carcinogenesis, and moreover, the loss or decrease of SST2R gene expression was significantly negatively correlated with the overexpression of tumor angiogenesis correlated p53 and ras genes, suggesting that SST2R gene together with p53 and ras genes may participate in pancreatic cancerous angiogenesis.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717065 | PMC |
| http://dx.doi.org/10.3748/wjg.v10.i1.132 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Chronic mild stress alters the somatostatin receptors in the rat brain.
Psychopharmacology (Berl)
January 2016
Rationale: The involvement of somatostatin (SST) and its receptors in the pathophysiology of depression and stress has been evidenced by numerous studies.
Objectives: The purpose of the present study was to find whether chronic mild stress (CMS), an animal model of depression, affects the SST receptors in the rat brain and pituitary, as well as the level of SST in plasma.
Methods: In CMS model, rats were subjected to 2 weeks of stress and behaviorally characterized using the sucrose consumption test into differently reacting groups based on their response to stress, i.
Sexually dimorphic distribution of sst2A receptors on growth hormone-releasing hormone neurones in mice: modulation by gonadal steroids.
J Neuroendocrinol
November 2008
UMR 894 INSERM, Centre de Psychiatrie et de Neurosciences, 2ter rue d'Alésia, Paris, France.
The ultradian pulsatile pattern of growth hormone (GH) secretion is markedly sexually dimorphic in rodents as in primates, but the neuroanatomical mechanisms of this phenomenon are not clear. In the arcuate nucleus of the hypothalamus, GH-releasing hormone (GHRH) neurones receive somatostatinergic inputs through the sst2A receptor (sst2A-R) and the percentage of GHRH neurones bearing sst2A-R is higher in female than in male GHRH-enhanced green fluorescent protein (eGFP) mice. In the present study, we hypothesised that sst2A-R expression on GHRH neurones is modulated by gonadal steroids and constitutes a mechanism for sexually differentiated GH secretion.
View Article and Find Full Text PDFAlteration of somatostatin receptor subtype 2 gene expression in pancreatic tumor angiogenesis.
World J Gastroenterol
January 2004
Department of Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei, Province, China.
Article Synopsis
- The study aimed to investigate the expression levels of somatostatin receptor subtype 2 (SST2R) in pancreatic cancer tissues compared to adjacent non-cancerous tissues, and its link to genes involved in tumor angiogenesis.
- Out of 40 pancreatic cancer patients, a significant majority (87.5%) showed negative SST2R expression in cancer tissues, while 85% of adjacent tissues were positive, indicating a notable difference in SST2R expression levels between the two types of tissue.
- Additionally, SST2R expression correlated negatively with the tumor suppressor genes p53 and ras, suggesting that decreased SST2R levels may contribute to pancreatic carcinogenesis and could influence treatment outcomes with somatostatin analogs.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!